even these mild cases should be treated clinically

Despite being around for over ten years the erectile dysfunction medication Viagra is still undergoing testing. The latest clinical tests with Viagra were recently released at the 12th Congress of the European Society for Sexual Medicine (ESSM) taking place in Lyon, France and show yet again that the drug is both safe and effective. This particular study was targeted at men suffering from mild erectile dysfunction and was designed to see whether a clinically relevant benefit could be justified. 

The study which was done using firstly an 8 week, double blind, placebo controlled trial and then a follow up study of an open label format over six weeks saw statistically relevant results in the majority of the 150 volunteers. Two thirds of the men reported 100 percent satisfaction with the hardness of their erections. The results were recorded using the  (which has been adopted as the measuring standard for practically all impotence related clinical trials.)

All of the men who took part in the study had been suffering from mild erectile dysfunction for the least three months and had Erectile Function scores of between 22 and 25 which improved in practically every single case. It was seen that the results were slightly better at the end of the open label section of the clinical study than they were with the double blind treatment phase.

This is interesting because it adds weight to the theory that when men know that they have been given Viagra Cialis or Levitra it improves their erectile function over and above what would normally be expected from the drug alone. The confidence that these drugs give men actually improve the quality of erectile function. This study which was different from most clinical studies of Viagra because it focused on men who only suffered from mild erectile dysfunction will be utilised by medical researchers to show that even these mild cases should be treated clinically because they can greatly improve quality of life.

Professor Serge Carrier from the McGill University in Canada explained that even mild erectile dysfunction could have a negative effect on the quality of life of men and should be considered to be as serious from a psychological point of view as moderate or severe erectile dysfunction.

Financing for this clinical study came from Viagra’s manufacturer Pfizer.